References

Clostridioides difficile pathogenesis and control

10.1038/s41579-025-01242-2 · 2025 · External reference

Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea

10.1128/jcm.38.6.2386-2388.2000 · 2000 · External reference

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes

10.1016/j.jinf.2009.03.010 · 2009 · External reference

Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection

10.1001/jamainternmed.2016.9045 · 2017 · External reference

Toxin B is essential for virulence of Clostridium difficile

10.1038/nature07822 · 2009 · External reference

The role of toxin A and toxin B in Clostridium difficile infection

10.1038/nature09397 · 2010 · External reference

Effect of endogenous Clostridioides difficile toxin antibodies on recurrence of C. difficile infection

10.1093/cid/ciz809 · 2020 · External reference

Bezlotoxumab for prevention of recurrent Clostridium difficile infection

10.1056/nejmoa1602615 · 2017 · External reference

Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease

10.1093/infdis/jis669 · 2013 · External reference

The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection

10.1016/j.anaerobe.2024.102842 · 2024 · External reference

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)

10.1016/j.vaccine.2009.10.144 · 2010 · External reference

Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models

10.1093/infdis/jir748 · 2012 · External reference

A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice

10.1093/infdis/jiu196 · 2014 · External reference

Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A

10.1128/iai.01577-08 · 2009 · External reference

Anti-toxin antibody is not associated with recurrent Clostridium difficile infection

10.1016/j.anaerobe.2020.102299 · 2021 · External reference

Structure of the full-length Clostridium difficile toxin B

10.1038/s41594-019-0268-0 · 2019 · External reference

Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis

10.1128/iai.02316-14 · 2015 · External reference

Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium

10.1186/1471-2180-8-192 · 2008 · External reference

Identification of toxemia in patients with Clostridium difficile infection

2015 · External reference

A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection

10.1128/iai.00215-12 · 2012 · External reference

A comparative study of the use of stratified cross-validation and distribution-balanced stratified cross-validation in imbalanced learning

10.3390/s23042333 · 2023 · External reference

Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection

10.1002/bimj.200710415 · 2008 · External reference

Multicollinearity in regression analyses conducted in epidemiologic studies

10.4172/2161-1165.1000227 · 2016 · External reference

A review of goodness of fit statistics for use in the development of logistic regression models

10.1093/oxfordjournals.aje.a113284 · 1982 · External reference

A probiotic yeast-based immunotherapy against Clostridioides difficile infection

10.1126/scitranslmed.aax4905 · 2020 · External reference

Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

10.1093/cid/ciy149 · 2018 · External reference

Epitope conservation of AZD5148, a broadly neutralizing anti-toxin B monoclonal antibody, among diverse and global contemporary Clostridioides difficile isolates

10.1093/infdis/jiaf423 · 2025 · External reference

Review article: safety of live biotherapeutic products used for the prevention of Clostridioides difficile infection recurrence

10.1093/cid/ciad642 · 2023 · External reference

Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review

10.1371/journal.pone.0098400 · 2014 · External reference